Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,674,596
+$476,306 QoQ
Shares Held
9,853
-10.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#333
of 844 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $18,791,753 across 11 Diagnostics & Research names. NTRA ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,365 | $5,196,596 | |
| 2 | ILMN |
Illumina, Inc.
|
25,513 | $4,485,950 | |
| 3 | NTRA |
Natera, Inc.
This page
|
9,853 | $2,674,596 | |
| 4 | A |
Agilent Technologies, Inc.
|
12,937 | $1,718,421 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
8,032 | $1,551,943 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,142 | $1,134,381 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
1,476 | $777,025 | |
| 8 | DHR |
Danaher Corp /De/
|
3,367 | $641,346 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,674,596 | 9,853 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,198,290 | 10,992 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,048,500 | 13,307 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,691,794 | 10,510 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,081,340 | 12,320 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,354,424 | 9,578 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,086,729 | 6,865 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $821,239 | 6,469 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $455,792 | 4,209 | Shares | Sole | 2024-07-22 | |
| No filing history on record for this holder in this stock. | ||||||